General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.
作者信息
Sud Rishi, Tiwari Neha, Forner Patrice, Dowdell Lisa, Freiman John, Zekry Amany
机构信息
Department of Gastroenterology, St George Hospital, Sydney, New South Wales, Australia.
出版信息
Intern Med J. 2018 Jan;48(1):105-106. doi: 10.1111/imj.13662.
PMID:29314510
Abstract
摘要
相似文献
1
General practitioners require more support to prescribe direct acting antiviral therapy for hepatitis C.全科医生在开具丙型肝炎直接抗病毒治疗药物处方方面需要更多支持。
Intern Med J. 2018 Jan;48(1):105-106. doi: 10.1111/imj.13662.
2
Aiming for elimination: Outcomes of a consultation pathway supporting regional general practitioners to prescribe direct-acting antiviral therapy for hepatitis C.以消除为目标：支持地区全科医生开具丙型肝炎直接抗病毒疗法的咨询途径的结果
J Viral Hepat. 2018 Sep;25(9):1089-1098. doi: 10.1111/jvh.12910. Epub 2018 May 8.
3
A survey of hepatitis C management by Victorian GPs after PBS-listing of direct-acting antiviral therapy.直接作用抗病毒疗法纳入药品福利计划后，维多利亚州全科医生对丙型肝炎管理情况的调查。
Aust Fam Physician. 2017;46(4):235-240.
4
Direct-acting antiviral treatment for hepatitis C.丙型肝炎的直接抗病毒治疗
Lancet. 2019 Apr 6;393(10179):1392-1394. doi: 10.1016/S0140-6736(18)32326-2. Epub 2019 Feb 11.
5
Direct-acting antiviral therapy for hepatitis E virus?戊型肝炎病毒的直接抗病毒治疗？
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):154-155. doi: 10.1016/S2468-1253(16)30242-4. Epub 2017 Feb 9.
6
Editorial: hepatitis C direct acting antiviral agents and the kidney-authors' reply.社论：丙型肝炎直接抗病毒药物与肾脏——作者回复
Aliment Pharmacol Ther. 2017 Aug;46(3):379-380. doi: 10.1111/apt.14187.
7
Concerns About Direct-Acting Antiviral Agents for Hepatitis C-Cause for Reassurance.对丙型肝炎直接抗病毒药物的担忧——令人安心的理由
JAMA Netw Open. 2019 Jun 5;2(6):e194757. doi: 10.1001/jamanetworkopen.2019.4757.
8
New Direct-Acting Antiviral Agents Can Be Hepatotoxic in Patients With Hepatitis C Virus Infection and Decompensated Cirrhosis.新型直接抗病毒药物可能对丙型肝炎病毒感染且失代偿期肝硬化患者具有肝毒性。
Clin Gastroenterol Hepatol. 2016 Nov;14(11):1669-1671. doi: 10.1016/j.cgh.2016.06.009. Epub 2016 Jun 18.
9
'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.终末期肾病患者使用丙型肝炎病毒直接抗病毒药物的“真实世界”经验。
Int J Artif Organs. 2018 Jul;41(7):363-370. doi: 10.1177/0391398818763478. Epub 2018 Mar 27.
10
Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.对帕德马纳班和迪克西特的回复：丙型肝炎病毒进入抑制剂，用于优化基于直接作用抗病毒药物的治疗。
Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4527-E4529. doi: 10.1073/pnas.1705234114. Epub 2017 May 16.
引用本文的文献
1
Prescribing direct-acting antivirals for hepatitis C treatment: a scoping review of factors that influence primary care providers.开具用于丙型肝炎治疗的直接抗病毒药物：对影响初级保健提供者的因素的范围综述
BMC Prim Care. 2025 May 13;26(1):157. doi: 10.1186/s12875-025-02865-3.
Zotero 插件